Cargando…
Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
Background: Available neuroendocrine biomarkers are considered to have insufficient accuracy to discriminate patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) from healthy controls. Recent studies have demonstrated a potential role for circulating neuroendocrine specific transc...
Autores principales: | van Treijen, Mark J. C., Korse, Catharina M., van Leeuwaarde, Rachel S., Saveur, Lisette J., Vriens, Menno R., Verbeek, Wieke H. M., Tesselaar, Margot E. T., Valk, Gerlof D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288275/ https://www.ncbi.nlm.nih.gov/pubmed/30564197 http://dx.doi.org/10.3389/fendo.2018.00740 |
Ejemplares similares
-
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
por: van Treijen, Mark J C, et al.
Publicado: (2022) -
Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
por: Levy, Sonja, et al.
Publicado: (2020) -
Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base
por: van Treijen, Mark J C, et al.
Publicado: (2018) -
The Importance of an Early and Accurate MEN1 Diagnosis
por: de Laat, Joanne M., et al.
Publicado: (2018) -
Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs
por: van Vliembergen, Eline N. M., et al.
Publicado: (2023)